August M. Watanabe
Geen lopende functies
Profiel
In addition to Twilight Venture Partners, Dr. Watanabe is the Chairman of both Bio Crossroads and Marcadia Bio tech.
He is a Director of Ambrx, Endocyte, Kalypsys, QuatRx, and Reliant as well as Indiana University Foundation, the Regenstrief Foundation and Christel House International.
He is also worked as Senior Advisor to Frazier Healthcare Ventures.
He retired from Eli Lilly & Company in June, 2003 as Executive Vice President of Science and Technology and a Director.
He joined Eli Lilly & Company as vice president of Lilly Research Laboratories, where he was also elected to the Board and named Head of Research and Development.
Dr. Watanabe had previously been a full time faculty member at Indiana University School of Medicine, where he was also a professor of medicine and Chairman of the Department of Medicine.
Dr. Watanabe received his education and training at Wheaton College, Indiana University School of Medicine, Indiana University Medical Center and the National Institute of Mental Health.
He has served as an officer of the American College of Cardiology and the American Heart Association and as a consultant to the National Institutes of Health and the Food and Drug Administration.
He is the author, co-author or editor of numerous peer reviewed scientific publications, medical books and book chapters, and he has served on the editorial boards of multiple scientific journals.
Eerdere bekende functies van August M. Watanabe
| Bedrijven | Functie | Einde |
|---|---|---|
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Directeur/Bestuurslid | 09-06-2009 |
Indiana University Foundation, Inc.
 Indiana University Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous Indiana University Foundation provides financial support to education and charitable causes. The company was founded in 1936 and is headquartered in Bloomington, IN. | Directeur/Bestuurslid | 09-06-2009 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Directeur/Bestuurslid | 09-06-2009 |
Twilight Venture Partners LLC
 Twilight Venture Partners LLC Investment ManagersFinance Twilight Venture Partners LLC (Twilight Venture Partners) is a venture capital firm founded in 2002 by Jim R. Baumgardt, Harry L. Gonso, and Ronald D. Henriksen. The firm is headquartered in Indianapolis, Indiana. | Private Equity Investor | 01-06-2009 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 31-05-2009 |
Opleiding van August M. Watanabe
| Indiana University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
Twilight Venture Partners LLC
Twilight Venture Partners LLC Investment ManagersFinance Twilight Venture Partners LLC (Twilight Venture Partners) is a venture capital firm founded in 2002 by Jim R. Baumgardt, Harry L. Gonso, and Ronald D. Henriksen. The firm is headquartered in Indianapolis, Indiana. | Finance |
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Indiana University Foundation, Inc.
Indiana University Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous Indiana University Foundation provides financial support to education and charitable causes. The company was founded in 1936 and is headquartered in Bloomington, IN. | Miscellaneous |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
